Clinical Trial Update: Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow [Phase 2]

View source ↗

Summary

Phase II dose-ranging study of OrthoDerm Patch for tennis elbow (lateral epicondylitis) sponsored by Cure Therapeutics. The trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lateral Epicondylitis

Drugs mentioned

• OrthoDerm Patch

Snippet

Sponsor: Cure Therapeutics | Conditions: Tendonitis | Phase 2 | Status: UNKNOWN